Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53.

Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG, Marine JC.

Oncogene. 2005 Feb 17;24(8):1461-6.

PMID:
15608685
2.

DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.

Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A.

Nat Cell Biol. 2001 Jan;3(1):1-7.

PMID:
11146619
3.

E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF.

Mol Cell Biol. 2002 Aug;22(15):5308-18.

4.

The death associated protein (DAP) kinase homologue Dlk/ZIP kinase induces p19ARF- and p53-independent apoptosis.

Kögel D, Reimertz C, Düssmann H, Mech P, Scheidtmann KH, Prehn JH.

Eur J Cancer. 2003 Jan;39(2):249-56. Erratum in: Eur J Cancer. 2003 Jul;39(10):1466-8.

PMID:
12509958
5.

The ARF tumor suppressor: keeping Myc on a leash.

Gregory MA, Qi Y, Hann SR.

Cell Cycle. 2005 Feb;4(2):249-52. Epub 2005 Feb 21.

PMID:
15655352
6.

The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.

Craig AL, Chrystal JA, Fraser JA, Sphyris N, Lin Y, Harrison BJ, Scott MT, Dornreiter I, Hupp TR.

Mol Cell Biol. 2007 May;27(9):3542-55. Epub 2007 Mar 5.

7.

Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.

Matsuoka M, Kurita M, Sudo H, Mizumoto K, Nishimoto I, Ogata E.

Biochem Biophys Res Commun. 2003 Feb 21;301(4):1000-10. Erratum in: Biochem Biophys Res Commun. 2004 Mar 19;315(4):1165.

PMID:
12589812
8.

Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.

Jackson MW, Agarwal MK, Agarwal ML, Agarwal A, Stanhope-Baker P, Williams BR, Stark GR.

Oncogene. 2004 May 27;23(25):4477-87.

PMID:
15064747
10.

Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.

Moore L, Venkatachalam S, Vogel H, Watt JC, Wu CL, Steinman H, Jones SN, Donehower LA.

Oncogene. 2003 Oct 30;22(49):7831-7.

PMID:
14586409
11.

Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.

Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.

Oncogene. 2001 Oct 25;20(48):6983-93.

12.

Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.

Maclean KH, Dorsey FC, Cleveland JL, Kastan MB.

J Clin Invest. 2008 Jan;118(1):79-88. Erratum in: J Clin Invest. 2008 Apr;118(4):1584.

13.

p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR.

Nature. 2004 Oct 7;431(7009):712-7. Epub 2004 Sep 8.

PMID:
15361884
14.

p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.

Omura-Minamisawa M, Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, Cohn SL, London WB, Yu AL.

Clin Cancer Res. 2001 Nov;7(11):3481-90.

15.

Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.

Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H.

Oncogene. 2003 Jul 31;22(31):4851-9.

PMID:
12894226
16.

The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA.

Cancer Cell. 2007 Oct;12(4):342-54.

17.

p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.

Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T.

Mol Cell Biol. 2002 Jan;22(1):370-7.

18.

Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.

Luo XJ, Li LL, Deng QP, Yu XF, Yang LF, Luo FJ, Xiao LB, Chen XY, Ye M, Liu JK, Cao Y.

Eur J Cancer. 2011 Jan;47(2):316-25. doi: 10.1016/j.ejca.2010.09.021. Epub 2010 Oct 11.

PMID:
20943371
19.

Arf induces p53-dependent and -independent antiproliferative genes.

Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF.

Cancer Res. 2003 Mar 1;63(5):1046-53.

20.

Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.

Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.

Oncogene. 2002 May 9;21(20):3149-61.

Supplemental Content

Support Center